Synthesis of an Inhibitor-Tethered Resin for Detection of Active Matrix Metalloproteinases Involved in Disease
- 11 July 2006
- journal article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 71 (16) , 5848-5854
- https://doi.org/10.1021/jo060058h
Abstract
Matrix metalloproteinases (MMPs), of which 26 members are known in humans, are implicated in a number of diseases. Their activity is strictly controlled, but when the biological control over the activity is lost, disease processes set in. In an attempt to delineate what MMP activity has gone awry in what diseases, including metastatic cancers that are of special interest to our laboratories, we conceived and synthesized two chromatographic resins incorporated with a multifunctional broad-spectrum inhibitor for MMPs. The broad-spectrum inhibitor contains three sterogentic centers and was synthesized in 13 steps. Two structural variants of the inhibitors were linked to the polymer support via disulfide moieties. These resins are intended for use in cellular systems to selectively fish out from a complex mixture of all cellular proteins the active MMP forms important for the specific disease for identification.Keywords
This publication has 15 references indexed in Scilit:
- Organic reactions in frozen water: Michael addition of amines and thiols to the dehydroalanine side chain of nocathiacinsTetrahedron Letters, 2004
- Simple One-Flask Method for the Preparation of Hydroxamic AcidsOrganic Letters, 2003
- Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasionCancer Letters, 2003
- Highly water-soluble matrix metalloproteinases inhibitors and their effects in a rat adjuvant-induced arthritis modelBioorganic & Medicinal Chemistry, 2002
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 Å crystal structureJournal of Molecular Biology, 2001
- Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatmentOncogene, 2000
- Inhibition of Membrane-Type 1 Matrix Metalloproteinase by Hydroxamate Inhibitors: An Examination of the Subsite PocketJournal of Medicinal Chemistry, 1998
- Use of 2,2′-dithiobis(5-nitropyridine) for the heterodimerization of cysteine containing peptides. Introduction of the 5-nitro-2-pyridinesulfenyl groupTetrahedron Letters, 1996